Genetic and Immunological Factors in Neuromyelitis Optica

Neuromyelitis optica (NMO) is an autoimmune disorder characterised by severe inflammation and demyelination of the optic nerves and spinal cord. Central to its pathogenesis are pathogenic autoantibodies directed against aquaporin-4 (AQP4), the principal water channel in astrocytic foot processes. Genetic predisposition is conferred predominantly by variation within the major histocompatibility complex, notably class II HLA alleles, and by structural variants affecting complement component genes. These genetic elements shape the selection and activation of autoreactive B cells, promote complement-mediated astrocyte injury and interact with T-cell subsets—particularly Th17 and regulatory T cells—to determine susceptibility and disease severity. Ethnic differences in allele frequencies contribute to the markedly heterogeneous global incidence, while emerging evidence highlights the influence of ancestral background on risk allele distribution. A deeper understanding of these genetic and immunological interfaces is guiding the development of targeted diagnostics and novel immunotherapies for NMO.

Research from Nature Portfolio

Whole-genome sequencing and large-scale SNP analysis have pinpointed two independent signals in the MHC region associated with AQP4-seropositive NMO. One signal reflects structural variation in complement component 4 genes, implicating dysregulated complement activation in astrocyte injury. Furthermore, Mendelian randomisation has demonstrated a causal link between systemic lupus erythematosus risk variants and NMO, suggesting shared genetic architecture with systemic autoimmunity rather than multiple sclerosis. In parallel, population-based studies in admixed Mexican cohorts have shown that higher proportions of Native American ancestry correlate with increased NMO risk. This work identified specific HLA-DRB1 and HLA-DQB1 alleles of Native American origin that predispose to disease, underscoring the impact of ancestral genomic backgrounds on NMO susceptibility and emphasising the need for population-tailored genetic risk assessment.

Genetic and Immunological Factors in Neuromyelitis Optica publication trend

The graph below shows the total number of articles in genetic and immunological factors in neuromyelitis optica across all publications each year (not limited to Nature Index journals).

Technical terms

Aquaporin-4 (AQP4): A water-channel protein on astrocyte endfeet targeted by pathogenic autoantibodies in NMO.

Human leucocyte antigen (HLA): A set of cell-surface proteins essential for antigen presentation that influence autoimmune risk.

Complement system: A cascade of serum proteins that, when activated, contributes to astrocyte injury in NMO.

Single nucleotide polymorphism (SNP): A common type of genetic variation used in association studies to identify susceptibility loci.

Mendelian randomisation: A method using genetic variants as proxies to infer causal relationships between traits or diseases.

References

1. A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica. Nature Communications (2018).
2. Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica. Frontiers in Immunology (2017).
3. A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder. Frontiers in Immunology (2021).
4. Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population. Scientific Reports (2020).
5. Multi-Level Analyses of Genome-Wide Association Study to Reveal Significant Risk Genes and Pathways in Neuromyelitis Optica Spectrum Disorder. Frontiers in Genetics (2021).
6. Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?. Multiple Sclerosis International (2012).